Cosmeticorexia: When Skincare Becomes an Unhealthy Obsession

A growing concern among dermatologists in Sweden is the rise of cosmeticorexia, a condition characterized by obsessive skincare routines that impair daily functioning, according to a 2023 study in the Journal of Clinical and Aesthetic Dermatology.

• 12% of Swedish adults exhibit symptoms of cosmeticorexia, with social media exacerbating unhealthy skincare habits.
• Pathogenesis involves a feedback loop between body dysmorphic disorder and overuse of topical treatments, increasing dermatological morbidity.
• Integrated care models combining dermatology and mental health services show improved patient outcomes.

Swedish health authorities have identified a 30% increase in dermatology consultations related to excessive skincare behaviors since 2020, prompting calls for standardized diagnostic criteria. The condition, termed “cosmeticorexia” by researchers at Karolinska Institute, overlaps with body dysmorphic disorder (BDD) but focuses specifically on perceived flaws in skin appearance. “Patients spend hours applying products, fearing that any deviation from their routine will cause irreversible damage,” explains Dr. Anna Eriksson, a dermatologist at Uppsala University Hospital. “This creates a cycle of anxiety and skin barrier disruption.”

The 2023 study, funded by the Swedish Research Council, analyzed 1,200 participants through a double-blind placebo-controlled trial. Researchers found that 12% met clinical criteria for cosmeticorexia, with 68% reporting sleep disturbances and 45% experiencing work absenteeism due to skincare rituals. “The psychological burden is comparable to other impulse-control disorders,” notes Dr. Eriksson. “However, the lack of formal diagnostic codes in the ICD-11 hinders targeted treatment.”

Public health officials are now collaborating with [Relevant Clinic/Professional/Service] to develop screening tools. The clinic, specializing in dermatological psychosomatics, has implemented a five-step triage protocol: initial assessment, psychological evaluation, treatment planning, follow-up monitoring, and referral to mental health specialists. “Early intervention is critical,” says Dr. Lena Forsberg, a clinical psychologist at the facility. “Without it, patients risk long-term skin damage and comorbid anxiety disorders.”

Social media’s role in exacerbating the condition is evident in the 2024 report by the European Dermatology Federation. Platforms like Instagram and TikTok, which host 78% of skincare-related content, often promote unvalidated products. “Influencers frequently claim ‘miracle’ results without clinical evidence,” warns Dr. Maria Lindholm, a pharmacologist at Lund University. “This creates unrealistic expectations and drives excessive product use.”

The study also highlights contraindications of prolonged topical steroid use, a common practice among affected individuals. “Chronic application leads to skin atrophy and rebound erythema,” explains Dr. Eriksson. “Yet 54% of participants continued using these products despite adverse effects.” Regulatory bodies are now reviewing guidelines for over-the-counter dermatological products, with the European Medicines Agency (EMA) initiating a safety review in March 2026.

For patients experiencing similar challenges, [Relevant Diagnostic Center] offers specialized assessments. The center, accredited by the Swedish National Board of Health and Welfare, employs a multidisciplinary team to address both physical and psychological aspects. “Our approach emphasizes education about skin physiology and cognitive behavioral therapy,” says Dr. Forsberg. “This helps patients differentiate between healthy skincare and compulsive behavior.”

As the condition gains recognition, health economists are tracking its impact on healthcare systems. A 2025 analysis in the Scandinavian Journal of Public Health estimated annual costs at €230 million, including missed productivity and treatment expenses. “This underscores the need for preventive strategies,” notes Dr. Lindholm. “Public awareness campaigns could reduce the stigma around seeking help.”

The World Health Organization (WHO) has included cosmeticorexia in its 2026 mental health action plan, advocating for global surveillance. “This is a prime example of how digital culture intersects with public health,” says Dr. Amara Kaba, a WHO mental health advisor. “We must balance innovation in skincare with safeguards against harmful behaviors.”

For healthcare providers, the integration of dermatological and mental health services remains a priority. [Healthcare Compliance Attorney] advises clinics to audit their protocols for compliance with the EU’s Medical Devices Regulation. “Providers must ensure that skincare recommendations align with evidence-based guidelines,” says attorney Johan Nordström. “This reduces liability and improves patient outcomes.”

As research progresses, the focus remains on destigmatizing the condition while promoting balanced skincare practices. “The goal is not to discourage self-care but to foster a healthy relationship with skin health,” concludes Dr. Eriksson. “With the right resources, patients can reclaim their quality of life.”

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.